Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes.

European Journal of Heart Failure
M YuzefpolskayaP C Colombo

Abstract

Infections are common following left ventricular assist device (LVAD) implantation and predict adverse events. Infections are frequent prior to LVAD implantation although their impact on postoperative outcomes remains unknown. Gut and nasal microbial imbalance may predispose to mucosal colonization with pathogens. Herein, we investigated the predictive role of pre-LVAD infections, and explored the association of nasal Staphylococcus aureus (SA) colonization and gut microbiota, on postoperative outcomes. Overall, 254 LVAD patients were retrospectively categorized based on pre-LVAD infection status: Group 1, bacterial/fungal bloodstream infection (BSI); Group 2, other bacterial/fungal; Group 3, viral; and Group 4, no infection. In a subset of patients, nasal SA colonization (n = 140) and pre-LVAD stool (n = 25) were analysed using 16S rRNA sequencing. A total of 75 (29%) patients had a pre-LVAD infection [Group 1: 22 (29%); Group 2: 41 (55%); Group 3: 12 (16%)]. Pre-LVAD BSIs were independent predictors of 1-year postoperative mortality and infections [Group 1 vs. 4: hazard ratio (HR) 2.70, P = 0.036 vs. HR 1.8, P = 0.046]. In an unadjusted analysis, pre-LVAD infections other than BSIs, INTERMACS profile ≤2, higher serum creatini...Continue Reading

References

Nov 8, 2005·International Journal of Cardiology·Shinji SatohNaoki Makino
Apr 1, 2008·The American Journal of Medicine·Nasia Safdar, Elisa A Bradley
Apr 30, 2008·The Annals of Thoracic Surgery·Pam M KimballVigneshwar Kasirajan
Jul 7, 2012·Journal of Cardiothoracic and Vascular Anesthesia·Matthew E CoveGraeme MacLaren
Jan 15, 2013·Circulation·Rachel J GordonUNKNOWN Ventricular Assist Device Infection Study Group
Dec 3, 2014·The American Journal of Cardiology·Vicente A Benites-ZapataW H Wilson Tang
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Nov 26, 2015·Science Advances·Cindy M LiuPaal Skytt Andersen
Jan 10, 2016·JACC. Heart Failure·Nir UrielRoberto M Lang
Feb 18, 2016·American Journal of Respiratory and Critical Care Medicine·Bianca HarrisEric G Pamer
May 28, 2016·Genome Medicine·Emmanuel MontassierDan Knights
Jul 22, 2017·The ISME Journal·Benjamin J CallahanSusan P Holmes
Aug 5, 2017·ESC Heart Failure·Mark LueddeNorbert Frey
Aug 7, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Shimon KusneShirish Huprikar
Mar 10, 2018·Journal of the American College of Cardiology·Martin KummenMarius Trøseid
Aug 9, 2018·Journal of Clinical Biochemistry and Nutrition·Yuji NaitoTomohisa Takagi
Dec 26, 2018·Circulation Research·Eelke BrandsmaDebby P Y Koonen
Feb 9, 2019·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Margaret M HannanJames K Kirklin
Mar 19, 2019·The New England Journal of Medicine·Mandeep R MehraUNKNOWN MOMENTUM 3 Investigators
May 31, 2019·World Journal of Gastroenterology : WJG·Jing LvJi-Han Wang
Nov 16, 2019·Science·Cristina Gil-CruzBurkhard Ludewig
Mar 7, 2020·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Melana YuzefpolskayaRyan T Demmer
Apr 12, 2020·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Chetan B PatelMandeep R Mehra

❮ Previous
Next ❯

Citations

Jun 17, 2021·European Journal of Heart Failure·Karen F Rosario, Adam D DeVore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.